Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Platelet-Derived Growth Factor beta | 6 | 2021 | 21 | 3.120 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 6 | 2022 | 27 | 3.000 |
Why?
|
| Myofibroblasts | 3 | 2022 | 22 | 1.550 |
Why?
|
| STAT1 Transcription Factor | 3 | 2020 | 37 | 1.410 |
Why?
|
| Adipogenesis | 3 | 2020 | 17 | 1.380 |
Why?
|
| Fibrosis | 7 | 2022 | 115 | 1.310 |
Why?
|
| Mice | 24 | 2023 | 4393 | 1.180 |
Why?
|
| Fibroblasts | 5 | 2022 | 152 | 1.100 |
Why?
|
| Adipose Tissue | 3 | 2017 | 179 | 1.080 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2020 | 77 | 0.960 |
Why?
|
| Point Mutation | 3 | 2021 | 60 | 0.950 |
Why?
|
| Signal Transduction | 8 | 2021 | 1335 | 0.930 |
Why?
|
| Animals | 26 | 2023 | 9927 | 0.900 |
Why?
|
| Homeodomain Proteins | 4 | 2018 | 74 | 0.850 |
Why?
|
| Integrases | 2 | 2021 | 39 | 0.850 |
Why?
|
| Skin | 3 | 2020 | 139 | 0.840 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 38 | 0.820 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 4 | 0.800 |
Why?
|
| Myoblasts, Skeletal | 1 | 2021 | 5 | 0.800 |
Why?
|
| Recombinases | 1 | 2021 | 5 | 0.770 |
Why?
|
| Re-Epithelialization | 1 | 2020 | 5 | 0.710 |
Why?
|
| Adipocytes | 2 | 2020 | 53 | 0.710 |
Why?
|
| Cell Differentiation | 8 | 2022 | 394 | 0.690 |
Why?
|
| Carotid Arteries | 1 | 2020 | 52 | 0.690 |
Why?
|
| Organogenesis | 3 | 2017 | 12 | 0.690 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2022 | 25 | 0.640 |
Why?
|
| Growth Disorders | 1 | 2017 | 20 | 0.590 |
Why?
|
| Stromal Cells | 1 | 2017 | 60 | 0.550 |
Why?
|
| Mutation | 3 | 2017 | 814 | 0.550 |
Why?
|
| beta Catenin | 3 | 2018 | 62 | 0.520 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 17 | 0.510 |
Why?
|
| Mice, Knockout | 7 | 2020 | 779 | 0.510 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 487 | 0.490 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 44 | 0.490 |
Why?
|
| Atherosclerosis | 1 | 2015 | 91 | 0.470 |
Why?
|
| Phenotype | 5 | 2020 | 663 | 0.450 |
Why?
|
| Wnt Proteins | 3 | 2018 | 32 | 0.450 |
Why?
|
| Gene Knock-In Techniques | 4 | 2020 | 18 | 0.430 |
Why?
|
| Scleroderma, Systemic | 1 | 2013 | 28 | 0.420 |
Why?
|
| Pituitary Gland | 2 | 2003 | 53 | 0.420 |
Why?
|
| Cell Lineage | 2 | 2017 | 44 | 0.410 |
Why?
|
| Cells, Cultured | 6 | 2021 | 968 | 0.390 |
Why?
|
| Pericytes | 1 | 2011 | 17 | 0.390 |
Why?
|
| Adipocytes, White | 1 | 2011 | 10 | 0.380 |
Why?
|
| Cell Proliferation | 4 | 2020 | 762 | 0.380 |
Why?
|
| Wound Healing | 2 | 2022 | 113 | 0.360 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 628 | 0.350 |
Why?
|
| Repressor Proteins | 3 | 2006 | 114 | 0.350 |
Why?
|
| Amino Acid Substitution | 2 | 2021 | 102 | 0.330 |
Why?
|
| Connective Tissue | 1 | 2009 | 4 | 0.330 |
Why?
|
| Cell Movement | 2 | 2021 | 352 | 0.320 |
Why?
|
| Kidney Diseases | 2 | 2020 | 59 | 0.300 |
Why?
|
| Brain | 1 | 2011 | 693 | 0.260 |
Why?
|
| Hair Follicle | 1 | 2005 | 8 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 1469 | 0.240 |
Why?
|
| Mitral Valve Prolapse | 1 | 2023 | 21 | 0.220 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 26 | 0.220 |
Why?
|
| Periodontal Ligament | 1 | 2022 | 2 | 0.210 |
Why?
|
| Flow Cytometry | 2 | 2015 | 282 | 0.210 |
Why?
|
| Molecular Biology | 1 | 2002 | 16 | 0.210 |
Why?
|
| Inflammation | 2 | 2017 | 594 | 0.200 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 12 | 0.200 |
Why?
|
| Chondrogenesis | 1 | 2021 | 23 | 0.190 |
Why?
|
| Osteogenesis | 1 | 2021 | 40 | 0.190 |
Why?
|
| Versicans | 1 | 2021 | 2 | 0.190 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 2 | 0.190 |
Why?
|
| Transcriptome | 1 | 2022 | 199 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 55 | 0.180 |
Why?
|
| Granulation Tissue | 1 | 2020 | 7 | 0.180 |
Why?
|
| Carotid Artery Injuries | 1 | 2020 | 12 | 0.180 |
Why?
|
| Endothelial Cells | 2 | 2023 | 324 | 0.180 |
Why?
|
| Base Sequence | 1 | 2021 | 573 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 117 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 54 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 111 | 0.170 |
Why?
|
| Actins | 1 | 2020 | 93 | 0.170 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 94 | 0.170 |
Why?
|
| RNA | 2 | 2022 | 105 | 0.170 |
Why?
|
| Homeostasis | 2 | 2011 | 114 | 0.160 |
Why?
|
| Collagen | 1 | 2020 | 147 | 0.160 |
Why?
|
| Female | 5 | 2018 | 14405 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 49 | 0.160 |
Why?
|
| Mesoderm | 3 | 2012 | 12 | 0.150 |
Why?
|
| Atrophy | 1 | 2017 | 14 | 0.150 |
Why?
|
| Hyperplasia | 1 | 2017 | 27 | 0.150 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 44 | 0.150 |
Why?
|
| Interferons | 1 | 2017 | 68 | 0.140 |
Why?
|
| Lipodystrophy | 1 | 2017 | 6 | 0.140 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2016 | 13 | 0.140 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 12 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2017 | 74 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 28 | 0.140 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 24 | 0.140 |
Why?
|
| Serpins | 1 | 2016 | 31 | 0.140 |
Why?
|
| Aorta | 1 | 2017 | 123 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 163 | 0.140 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 44 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2015 | 10 | 0.130 |
Why?
|
| Receptors, LDL | 1 | 2015 | 28 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 67 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 57 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 80 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2015 | 22 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 73 | 0.120 |
Why?
|
| Triglycerides | 1 | 2015 | 117 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 120 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 129 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2016 | 240 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 106 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2016 | 197 | 0.120 |
Why?
|
| Stem Cells | 1 | 2015 | 113 | 0.120 |
Why?
|
| Cholesterol | 1 | 2015 | 182 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2015 | 503 | 0.110 |
Why?
|
| Glioma | 1 | 2015 | 118 | 0.110 |
Why?
|
| Male | 3 | 2018 | 12826 | 0.110 |
Why?
|
| Humans | 9 | 2023 | 26749 | 0.110 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2013 | 5 | 0.110 |
Why?
|
| Imatinib Mesylate | 1 | 2013 | 11 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 322 | 0.110 |
Why?
|
| Benzamides | 1 | 2013 | 32 | 0.110 |
Why?
|
| Pregnancy | 1 | 2017 | 1126 | 0.100 |
Why?
|
| Radial Artery | 1 | 2012 | 21 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 45 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 128 | 0.100 |
Why?
|
| Jaw | 1 | 2012 | 4 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 439 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 68 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2013 | 120 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 142 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 288 | 0.100 |
Why?
|
| Lung | 2 | 2012 | 349 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2023 | 12 | 0.080 |
Why?
|
| Cytokines | 1 | 2011 | 439 | 0.080 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Histone Deacetylase 1 | 1 | 2006 | 10 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 446 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 22 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 86 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2006 | 206 | 0.060 |
Why?
|
| Craniofacial Abnormalities | 1 | 2004 | 3 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2004 | 30 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2023 | 58 | 0.050 |
Why?
|
| Transcription Factor HES-1 | 1 | 2003 | 6 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2023 | 511 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 27 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 439 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2022 | 35 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2003 | 47 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 60 | 0.050 |
Why?
|
| Genome, Human | 1 | 2002 | 71 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 11 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2021 | 24 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 33 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 43 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1391 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 239 | 0.040 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 3 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 34 | 0.040 |
Why?
|
| Kidney | 1 | 2020 | 275 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2021 | 466 | 0.040 |
Why?
|
| Axin Protein | 1 | 2016 | 3 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2016 | 19 | 0.040 |
Why?
|
| Transfection | 1 | 2016 | 312 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 152 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2015 | 3 | 0.030 |
Why?
|
| DNA, Circular | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2015 | 12 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 72 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 671 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 189 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 347 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 662 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 446 | 0.030 |
Why?
|
| Apoptosis | 1 | 2016 | 736 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 1564 | 0.030 |
Why?
|
| Cell Division | 1 | 2012 | 153 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2016 | 623 | 0.030 |
Why?
|
| Epithelium | 1 | 2012 | 39 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 81 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2004 | 6 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 14 | 0.010 |
Why?
|
| Occipital Bone | 1 | 2004 | 10 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 31 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2004 | 21 | 0.010 |
Why?
|
| Cleft Palate | 1 | 2004 | 12 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 78 | 0.010 |
Why?
|
| Mandible | 1 | 2004 | 41 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 40 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 482 | 0.010 |
Why?
|